Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal type-1 receptor 4 (VN1R4) is a human protein that belongs to the vomeronasal type-1 receptor family, which are putative pheromone receptors participating in chemical signaling related to social and reproductive behaviors. VN1R4 is a predicted G protein-coupled receptor (GPCR) involved in the response to pheromones and is thought to mediate certain chemosensory signals, potentially influencing sensory perception and behavior. Although the vomeronasal system and its receptors (including VN1R4) play prominent roles in pheromone detection in many mammals, their functional relevance in adult humans remains disputed, as the human vomeronasal organ is largely vestigial and most vomeronasal receptor genes are pseudogenes or have unproven activity. No pharmaceuticals currently target VN1R4, and there are no established clinical biomarkers or widely recognized disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal type-1 receptor 4 (VN1R4).